DB Power and LPA announce strategic partnership to globally expand solutions for issuers of structured retail products

Real Time Search
CES A80 :
CES HKMI :
CES 120 :
Total Turn.

01061 ESSEX BIO-TECH

Trading Add to Porfolio
Index Constituent : None
Major Shareholders Ngiam Mia Je Patrick (27.15%)
Ngiam Mia Kiat Benjamin (26.81%)
Sector Health Care & Biotechnology
Web Site http://www.essexbio.com Tel (852) 2587-7838
Email essex@essexbio.com Fax (852) 2587-7363
Related Equities N/A
Principal Activities Principally engaged in investment holding, and development, manufacture and sale of biologic drugs in the People’s Republic of China (the “PRC”).

Consolidated List of Substantial Shareholders

Name Number of Shares Interested % of Issued Share Capital (%) Date of Last Notice Filed (Y/M/D)
劉慧娟 153,645,667(L)  26.98(L)  19/04/2018
嚴名熾 153,645,667(L)  26.98(L)  19/04/2018
嚴名杰 152,020,667(L)  26.67(L)  30/04/2018
Last Update : 2019-02-28
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool

Complete List of Directors

Director's Name Number of Shares Interested % of issued share capital (%) Date of Last Notice Filed (Y/M/D)
嚴名熾 153,645,667(L)  26.98(L)  19/04/2018
Last Update : 2019-02-28
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Back to Top